Kane Biotech Inc.
KNBIF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$607 | -$349 | -$1,218 | -$1,083 |
| Dep. & Amort. | $36 | $46 | $48 | $64 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $24 | -$239 | $145 | $142 |
| Change in WC | -$149 | -$345 | -$135 | -$4,775 |
| Other Non-Cash | -$2 | $113 | $57 | $5,232 |
| Operating Cash Flow | -$698 | -$773 | -$1,104 | -$420 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$6 | -$50 | -$14 | -$4 |
| Net Acquisitions | $0 | $0 | $0 | $73 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $60 | $9 | -$31 | -$37 |
| Investing Cash Flow | $54 | -$41 | -$45 | $32 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$21 | $887 | -$155 | -$154 |
| Stock Issued | $0 | $1,086 | $1,451 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$9 | -$40 | -$13 | $357 |
| Financing Cash Flow | -$30 | $1,933 | $1,283 | $203 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$674 | $1,119 | $135 | -$186 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,613 | $494 | $359 | $544 |
| End Cash | $939 | $1,613 | $494 | $359 |
| Free Cash Flow | -$704 | -$823 | -$1,149 | -$461 |